Site Search

Share

X

Search Results

New Survey: 1 in 10 Cancer Patients Has Been Impacted by Nation’s Drug Shortages with Significant Delays to Cancer Care

... the current issue as well as prevent future crises.”  In addition to the impact of the current drug shortages, respondents were asked if biomarker testing, an increasingly important tool in cancer care, had changed the course of their treatment. An overwhelming majority of respondents (77%) who have had biomarker testing agreed that the results gave their provider valuable information that led to better treatment, with the same number (77%) of ...

Ohio is One Step Closer to Unlocking Precision Medicine

... advocacy organizations, medical associations, and health systems are asking members of the Ohio House Insurance Committee to support HB 608: biomarker testing legislation. This legislation would ensure more Ohioans’ can access game-changing testing which helps ensure patients get the right treatment at the right time by allowing doctors to precisely target a patient’s individual cancer. More information on the biomarker testing legislation and the current list of industry support can be found here.  Ohio is One Step Closer to Unlocking Precision Medicine ...

Time for Mills to Bring Precision Medicine to all Mainers

... – Last week, The Appropriations and Financial Affairs Committee voted to fund LD 1577  An Act to Require Health Insurance Coverage for Biomarker Testing.  This legislation, which passed both House and Senate chambers earlier this month with broad bipartisan support, would increase access to  biomarker testing  for Mainers who need it, ensuring they can receive the right treatment at the right time for their disease. The following can ...

Patient Advocates Send Message to State Leaders: ‘Defend Medicaid Access to Precision Medicine'

... more than a dozen cancer survivors and ACS CAN advocates gathered at the New York State Capitol to call on lawmakers to preserve access to biomarker testing,  a priority shared by over 100 organizations statewide . Advocates also expressed hope that the one‑house and final budgets will ... survivors and advocates distributed flyers to policymakers and attendees, urging them to oppose a proposed roll back of Medicaid coverage for biomarker testing, a tool that helps physicians understand a tumor’s unique characteristics and can guide personalized, targeted ...

Senate Votes to Remove Barriers to Precision Treatments

INDIANAPOLIS, IN  – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance ... is a statement from Allie Kast, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Indiana: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of ...

Legislature Votes to Remove Barriers to Precision Treatments

... sent Senate Bill 273 to the Governor’s desk for signing. This legislation will ensure that more insurance plans in the Hoosier state cover biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments.  “Biomarker testing has given me better, more effective treatment options, a better chance of surviving cancer and more time with my family,” said ...

Ensuring Access to Quality Care

... that create barriers or reduce access to care for cancer patients, survivors, and those who could be diagnosed with cancer.  Access to Biomarker Testing : ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

Coverage Analysis of Tumor Biormarker Diagnostics

Biomarker testing is critical to successfully realizing personalized medicine, both through the selection of appropriate targeted therapies as well as by directing patients to relevant clinical trials.  This report examines the private payer landscape of coverage for tumor biomarker tests in lung, breast and colorectal cancer.   The report was compiled in 2018, and indications are that coverage has improved since ...

Advocates Call on Lawmakers to Increase Tobacco Prevention Efforts and Pass Biomarker Legislation to Enhance Access to Lifesaving Care

... “To improve access to care for those who hear the words “you have cancer,” ACS CAN also calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role ...

Advocates to Gather at General Assembly for Cancer Action Day

... be available for interviews. The volunteers with the American Cancer Society Cancer Action Network (ACS CAN) will talk with lawmakers about biomarker testing coverage, which is a routine test performed after a cancer diagnosis that allows physicians to match patients with the most effective ... to disparities. “It changed my life to be told I had cancer at only 23 years old,” said volunteer Ethan Davis , who benefited from biomarker testing and will be available for interviews. “I went from being a healthy young adult to having brain surgery days later. Biomarker ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy